
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sec8 CRISPR/Cas9 KO Plasmid (m) | sc-422866 | 20 µg | $397.00 |
Exoc4 encodes Sec8, an essential subunit of the octameric exocyst complex that mediates tethering of secretory vesicles to defined plasma membrane sites prior to SNARE-dependent fusion. In mouse cells, Sec8 helps coordinate polarized exocytosis and membrane trafficking that support processes such as epithelial polarity, neurite outgrowth, cytokinesis, and receptor recycling, integrating signals from small GTPases including Ral, Rab, and Cdc42. Exocyst function is closely linked to cytoskeletal remodeling and directed cell migration, making Sec8 a useful node for studying pathways that govern tissue organization and intracellular transport fidelity. Dysregulation of exocyst-dependent trafficking has been associated with altered cell polarity and aberrant signaling dynamics relevant to developmental and neurobiology research.
Sec8 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Exoc4 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Exoc4 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Exoc4 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sec8 protein expression.
This CRISPR knockout system enables efficient generation of Exoc4-deficient cell models for investigation of Sec8 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.